Biotechnology Assets SA
MAD:BST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Biotechnology Assets SA
Total Current Assets
Biotechnology Assets SA
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biotechnology Assets SA
MAD:BST
|
Total Current Assets
€3.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-3%
|
|
|
Grifols SA
MAD:GRF
|
Total Current Assets
€5.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
Oryzon Genomics SA
MAD:ORY
|
Total Current Assets
€30.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
|
Pharma Mar SA
MAD:PHM
|
Total Current Assets
€283.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
10%
|
|
Biotechnology Assets SA
Glance View
Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.
See Also
What is Biotechnology Assets SA's Total Current Assets?
Total Current Assets
3.2m
EUR
Based on the financial report for Jun 30, 2025, Biotechnology Assets SA's Total Current Assets amounts to 3.2m EUR.
What is Biotechnology Assets SA's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
-3%
Over the last year, the Total Current Assets growth was 10%. The average annual Total Current Assets growth rates for Biotechnology Assets SA have been -11% over the past three years , -34% over the past five years , and -3% over the past ten years .
